Results 121 to 130 of about 164,596 (212)

Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms. [PDF]

Clin Epigenetics
Yu X, Jia L, Tang Q, Zhou Q, Wang G, Wang S.   +5 more
europepmc   +1 more source

ABCC6 Transporter Contributed to Cisplatin Resistance on Bladder Cancer. [PDF]

Int J Med Sci
Chou KY, Chang AC, Hwang TI, Tsai TF, Ho CY, Liu HW, Achudhan D, Tang CH, Lin YY.   +8 more
europepmc   +1 more source

SLC25A10 promotes cisplatin resistance by inhibiting ferroptosis in cervical cancer. [PDF]

Cell Death Discov
Ma C, Lu X, Ni C, Gao Y, Yang F, Chen S, Du Y, Zhao F, Cao Y, Huang H.   +9 more
europepmc   +1 more source

Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy. [PDF]

Int J Nanomedicine
Lei SY, Qin H, Liu S, Sheng J.
europepmc   +1 more source

LINC00473 modulates protein expression to promote ovarian cancer progression and overcome cisplatin resistance. [PDF]

Oncol Lett
Zhang C, Ma J, Wang W, Guo M, Han C, Sadike M, Zhu K.   +6 more
europepmc   +1 more source

HnRPD/AUF1 facilitates human ovarian cancer progression through activating FLI1 and maintaining cisplatin resistance. [PDF]

Mol Cancer
Tang C, Zhu C, An Z, Cao B, Xu Q, Li L, Bao Y, Li J.   +7 more
europepmc   +1 more source

Targeting ANXA4 to Overcome Cisplatin Resistance in Ovarian Cancer: A Bioinformatics and in Vitro Study. [PDF]

Onco Targets Ther
Wang Y, Xie Q.
europepmc   +1 more source

Efficacy and mechanisms of cisplatin and sulforaphane nanoparticles in alleviating cisplatin resistance in non-small cell lung cancer. [PDF]

Transl Lung Cancer Res
Pang S, Lin Q, Pang T, Hou J, Li P, Guo E, Ren F, Kong X, Wang Y, Yan Y, Yan X, Chen L, Liu M, Gu A, Wang J, Xu S.   +15 more
europepmc   +1 more source

Uncovering a novel treatment strategy: sodium butyrate overcomes cisplatin resistance in the oral squamous cell carcinoma by inducing ferroptosis. [PDF]

J Exp Clin Cancer Res
Wang B, Li W, Bai Y, Su Z, Zeng Q, Lv C, Hu Q, Cheng B, Tao X.   +8 more
europepmc   +1 more source

Mechanistic insights into a novel GPX4 inhibitor Compound AI-3p reversing cisplatin-resistance in ovarian cancer cells. [PDF]

J Ovarian Res
Wang B, Li D, Lai L, Lu Y, Wang TA, Song J, Wei P, Hou H, Zhang M, Wang C.   +9 more
europepmc   +1 more source